Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

Abstract

Biologic treatment with mepolizumab or omalizumab for severe asthma-induced asthma remission in a subgroup of patients. Remission on treatment may be an achievable treatment target and future studies should consider remission as an outcome measure.